|
ZNF100 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.260200E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.172000E-04 |
| Normal-vs-Stage2 |
6.519000E-01 |
| Normal-vs-Stage3 |
2.697800E-02 |
| Normal-vs-Stage4 |
1.097630E-01 |
| Stage1-vs-Stage2 |
1.811880E-02 |
| Stage1-vs-Stage3 |
5.106600E-01 |
| Stage1-vs-Stage4 |
4.531400E-01 |
| Stage2-vs-Stage3 |
4.923600E-02 |
| Stage2-vs-Stage4 |
1.181410E-01 |
| Stage3-vs-Stage4 |
8.462400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.238300E-04 |
| Normal-vs-AfricanAmerican |
6.400300E-02 |
| Normal-vs-Asian |
7.038400E-02 |
| Caucasian-vs-AfricanAmerican |
5.541200E-01 |
| Caucasian-vs-Asian |
8.802200E-01 |
| AfricanAmerican-vs-Asian |
5.524400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.760100E-02 |
| Normal-vs-Female |
2.197000E-03 |
| Male-vs-Female |
4.740600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.572400E-04 |
| Normal-vs-Age(41-60Yrs) |
4.124100E-02 |
| Normal-vs-Age(61-80Yrs) |
2.110400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.781150E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.065800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.854400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.890200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.525200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.415830E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.414000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.988000E-01 |
| Classical-VS-Follicular |
2.95170554664992E-11 |
| Classical-VS-Other |
6.239400E-01 |
| Classical-VS-Normal |
1.41750000004492E-06 |
| Tall-VS-Follicular |
2.03919999999247E-05 |
| Tall-VS-Other |
6.006200E-01 |
| Tall-VS-Normal |
6.157800E-03 |
| Follicular-VS-Other |
7.075500E-02 |
| Follicular-VS-Normal |
5.442400E-03 |
| Other-VS-Normal |
4.947600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.542200E-01 |
| Normal-vs-N1 |
8.395700E-03 |
| N0-vs-N1 |
6.989700E-02 |
|
|
